Gregor Miller

Gregor Miller

Auto-generated profile, based on publicly available information

Gregor Miller

Core Facility Statistical Consulting, Helmholtz Center Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2022 in Nature Cardiovascular Research
Verified
Journal Article
Open access
PDF file
NSNadine Spielmann
Nadine Spielmann
GMGregor Miller
Gregor Miller
TOTudor I. Oprea
Tudor I. Oprea
CHChih-Wei Hsu
Chih-Wei Hsu
GFGisela Fobo
Gisela Fobo
MAMartin M. Hrabě de Angelis
Martin M. Hrabě de Angelis
Clinical presentation of congenital heart disease is heterogeneous, making identification of the disease-causing genes and their genetic pathways and mechanisms of action challenging. By using in vivo electrocardiography, transthoracic echocardiography and microcomputed tomography imaging to screen 3,894 single-gene-null mouse lines for structural and functional cardiac abnormalities, here we identify 705 lines with cardiac arrhythmia, myocardial hypertrophy and/or ventricular dilation. Among these 705 genes, 486 have not been previously associated with cardiac dysfunction in humans, and some of them represent variants of unknown relevance (VUR). Mice with mutations inCasz1,Dnajc18,Pde4dip,Rnf38orTmem161bgenes show developmental cardiac structural abnormalities, with their human orthologs being categorized as VUR. Using UK Biobank data, we validate the importance of theDNAJC18gene for cardiac homeostasis by showing that its loss of function is associated with altered left ventricular systolic function. Our results identify hundreds of previously unappreciated genes with potential function in congenital heart disease and suggest causal function of five VUR in congenital heart disease.

14 February 2020 in Mammalian Genome
Verified
Journal Article
Open access
PDF file
MTMouse Phenome Database Team
Mouse Phenome Database Team
HKHeike Kollmus
Heike Kollmus
HFHelmut Fuchs
Helmut Fuchs
CLChristoph Lengger
Christoph Lengger
HHHamed Haselimashhadi
Hamed Haselimashhadi
MAMartin M. Hrabě de Angelis
Martin M. Hrabě de Angelis
The collaborative cross (CC) is a large panel of mouse-inbred lines derived from eight founder strains (NOD/ShiLtJ, NZO/HILtJ, A/J, C57BL/6J, 129S1/SvImJ, CAST/EiJ, PWK/PhJ, and WSB/EiJ). Here, we performed a comprehensive and comparative phenotyping screening to identify phenotypic differences and similarities between the eight founder strains. In total, more than 300 parameters including allergy, behavior, cardiovascular, clinical blood chemistry, dysmorphology, bone and cartilage, energy metabolism, eye and vision, immunology, lung function, neurology, nociception, and pathology were analyzed; in most traits from sixteen females and sixteen males. We identified over 270 parameters that were significantly different between strains. This study highlights the value of the founder and CC strains for phenotype-genotype associations of many genetic traits that are highly relevant to human diseases. All data described here are publicly available from the mouse phenome database for analyses and downloads.

15 December 2020 in International Journal of Radiation Biology
Verified
Journal Article
Open access
MUMarie-Claire Ung
Marie-Claire Ung
LGLillian Garrett
Lillian Garrett
CDClaudia Dalke
Claudia Dalke
VLValentin Leitner
Valentin Leitner
DDDaniel Dragosa
Daniel Dragosa
Sabine M. HölterSabine M. Hölter
Sabine M. Hölter
The increasing use of low-dose ionizing radiation in medicine requires a systematic study of its long-term effects on the brain, behaviour and its possible association with neurodegenerative diseas...

28 December 2020 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
ASAnna L. Swan
Anna L. Swan
CSChristine Schütt
Christine Schütt
JRJan Rozman
Jan Rozman
MMMaria del Mar Muñiz Moreno
Maria del Mar Muñiz Moreno
SBStefan Brandmaier
Stefan Brandmaier
ICIMPC Consortium
IMPC Consortium
The genetic landscape of diseases associated with changes in bone mineral density (BMD), such as osteoporosis, is only partially understood. Here, we explored data from 3,823 mutant mouse strains for BMD, a measure that is frequently altered in a range of bone pathologies, including osteoporosis. A total of 200 genes were found to significantly affect BMD. This pool of BMD genes comprised 141 genes with previously unknown functions in bone biology and was complementary to pools derived from recent human studies. Nineteen of the 141 genes also caused skeletal abnormalities. Examination of the BMD genes in osteoclasts and osteoblasts underscored BMD pathways, including vesicle transport, in these cells and together with in silico bone turnover studies resulted in the prioritization of candidate genes for further investigation. Overall, the results add novel pathophysiological and molecular insight into bone health and disease.

17 January 2025 in Scientific Data
Verified
Journal Article
Open access
PDF file
GMGregor Miller
Gregor Miller
ESElmar Spiegel
Elmar Spiegel
Ensuring the integrity of research data is crucial for the accuracy and reproducibility of any data-based scientific study. This can only be achieved by establishing and implementing strict rules for the handling of research data. Essential steps for achieving high-quality data involve planning what data to gather, collecting it in the correct manner, and processing it in a robust and reproducible way. Despite its importance, a comprehensive framework detailing how to achieve data quality is currently unavailable. To address this gap, our study proposes guidelines designed to establish a reliable approach to data handling. They provide clear and practical instructions for the complete research process, including an overall data collection strategy, variable definitions, and data processing recommendations. In addition to raising awareness about potential pitfalls and establishing standardization in research data usage, the proposed guidelines serve as a reference for researchers to provide a consistent standard of data quality. Furthermore, they improve the robustness and reliability of the scientific landscape by emphasising the critical role of data quality in research.

8 November 2021 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
SVSilvia Vidali
Silvia Vidali
RGRaffaele Gerlini
Raffaele Gerlini
KTKyle Thompson
Kyle Thompson
JUJill E Urquhart
Jill E Urquhart
JMJana Meisterknecht
Jana Meisterknecht
MAMartin M. Hrabě de Angelis
Martin M. Hrabě de Angelis
Mitochondrial disorders are clinically and genetically diverse, with isolated complex III (CIII) deficiency being relatively rare. Here, we describe two affected cousins, presenting with recurrent episodes of severe lactic acidosis, hyperammonaemia, hypoglycaemia and encephalopathy. Genetic investigations in both cases identified a homozygous deletion of exons 2 and 3 of UQCRH , which encodes a structural complex III (CIII) subunit. We generated a mouse model with the equivalent homozygous Uqcrh deletion ( Uqcrh −/− ), which also presented with lactic acidosis and hyperammonaemia, but had a more severe, non‐episodic phenotype, resulting in failure to thrive and early death. The biochemical phenotypes observed in patient and Uqcrh −/− mouse tissues were remarkably similar, displaying impaired CIII activity, decreased molecular weight of fully assembled holoenzyme and an increase of an unexpected large supercomplex (S XL ), comprising mostly of one complex I (CI) dimer and one CIII dimer. This phenotypic similarity along with lentiviral rescue experiments in patient fibroblasts verifies the pathogenicity of the shared genetic defect, demonstrating that the Uqcrh −/− mouse is a valuable model for future studies of human CIII deficiency.